Comments

United Therapeutics

Q: What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

UTHRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$357.87

00.00%

Pre-Market: 4:00 PM EDT

15 minutes delayed

United Therapeutics (UTHR) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

United Therapeutics (NASDAQ:UTHR) Stock Quotes, Forecast and News Summary

United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	5.00 / 482.99K
Day Range	- - -
52 Wk Range	208.62 - 366.08
Market Cap	$15.92B
P/E Ratio	16.45
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	12.11%
Days to Cover	7.76

Recent News

Strength Seen in Foghorn Therapeutics: Can Its 9.5% Jump Turn into More Strength?

Foghorn Therapeutics Inc. (NASDAQ: FHTX) shares rallied 9.5% in the last trading session to close at $9.72. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 43.2% gain over the past four weeks.

Zacks

FDA Battles Backlog of Drug Factory Inspections Since COVID-19

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

Vandana Singh

Ambarella To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	5.00 / 482.99K
Day Range	- - -
52 Wk Range	208.62 - 366.08
Market Cap	$15.92B
P/E Ratio	16.45
Dividend Yield	-
Exchange	NASDAQ
RSI	62
Short Interest	12.11%
Days to Cover	7.76

About United Therapeutics Corp

Sector

Health Care

Industry

Biotechnology

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy United Therapeutics (UTHR) stock?

You can purchase shares of United Therapeutics (NASDAQ:UTHR) through any online brokerage.

View our list of the best stock brokerages

Who are United Therapeutics (UTHR) competitors?

Other companies in United Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for United Therapeutics (UTHR) stock?

United Therapeutics has a consensus price target of $335.94.

What is the current price for United Therapeutics (UTHR)?

The stock price for United Therapeutics (NASDAQ: UTHR) is $357.87 last updated September 24, 2024 at 4:00 PM EDT.

Does United Therapeutics (UTHR) pay a dividend?

There are no upcoming dividends for United Therapeutics.

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

United Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is United Therapeutics (UTHR) going to split?

There is no upcoming split for United Therapeutics.

What sector and industry does United Therapeutics (UTHR) operate in?

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge